The Top Line cover image

AbbVie, ADCs and the future of cancer care

The Top Line

00:00

Advancements in Antibody-Drug Conjugates for Cancer

This chapter explores the latest developments in antibody-drug conjugates (ADCs) for treating ovarian and colorectal cancers, showcasing promising new compounds and their effectiveness. It discusses the potential for combining ADCs with existing therapies and highlights the importance of precision medicine in oncology.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app